| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 425.354.550 $ | +48.001.068 $ | +27,4 % | 10 | 392.982.903 $ | +85.925.942 $ | +22,7 % | 9 | 261.535.875 $ | +165.867.380 $ | +314,9 % | 6 | ||||
| Abivax S.A. | ABVX | → 0 | Schwach | 60.429.200 $ | -27.115.834 $ | -31,0 % | 1 | 87.545.034 $ | +19.521.116 $ | +28,7 % | 1 | 68.023.918 $ | +63.261.954 $ | +1.328,5 % | 1 |
| ALUMIS INC. | ALMS | → 0 | Neutral | 70.541.712 $ | +39.934.811 $ | +130,5 % | 1 | 30.606.901 $ | +30.606.901 $ | 1 | |||||
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Neutral | 60.463.402 $ | +6.145.839 $ | +11,3 % | 1 | 54.317.563 $ | -8.262.729 $ | -13,2 % | 1 | 62.580.292 $ | +41.680.038 $ | +199,4 % | 1 |
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 47.913.555 $ | +11.050.463 $ | +30,0 % | 1 | 36.863.092 $ | +8.463.447 $ | +29,8 % | 1 | 28.399.645 $ | +10.707.020 $ | +60,5 % | 1 |
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 43.230.113 $ | +14.150.524 $ | +48,7 % | 1 | 29.079.589 $ | +12.583.367 $ | +76,3 % | 1 | ||||
| Jazz Pharmaceuticals plc | JAZZ | → 0 | Neutral | 30.807.777 $ | -11.364.123 $ | -26,9 % | 1 | 42.171.900 $ | +2.551.502 $ | +6,4 % | 1 | 39.620.398 $ | +17.658.652 $ | +80,4 % | 1 |
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 34.985.329 $ | +1.153.296 $ | +3,4 % | 1 | 33.832.033 $ | +19.976.349 $ | +144,2 % | 1 | ||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 33.939.606 $ | +2.303.690 $ | +7,3 % | 1 | 31.635.916 $ | +9.521.933 $ | +43,1 % | 1 | ||||
| Immix Biopharma, Inc. | IMMX | → 0 | Neutral | 33.648.559 $ | +17.962.905 $ | +114,5 % | 1 | ||||||||
| Celcuity Inc. | CELC | → 0 | Schwach | 32.176.523 $ | +549.468 $ | +1,7 % | 1 | 31.627.055 $ | +8.219.952 $ | +35,1 % | 1 | ||||
| Disc Medicine, Inc. | IRON | → 0 | Schwach | 28.768.268 $ | +5.070.021 $ | +21,4 % | 1 | ||||||||
| X4 Pharmaceuticals, Inc | XFOR | → 0 | Neutral | 26.665.948 $ | +3.463.828 $ | +14,9 % | 1 | ||||||||
| 425.354.550 $ | +48.001.068 $ | +27,4 % | 10 | 392.982.903 $ | +85.925.942 $ | +22,7 % | 9 | 261.535.875 $ | +165.867.380 $ | +314,9 % | 6 | ||||